The GLP-1 Impact: How Weight Loss Drugs Are Reshaping Consumer Behavior
AI interviews with 300 consumers reveal how GLP-1 medications are fundamentally changing food, fashion, and lifestyle purchasing patterns.
Revelo Research Team
A Consumer Behavior Earthquake
The rapid adoption of GLP-1 medications like Ozempic and Wegovy isn't just a healthcare story — it's a consumer behavior revolution. We interviewed 300 consumers to understand the ripple effects across industries.
Key Findings
Food & Beverage Consumers on GLP-1 medications report dramatically different relationships with food. Portion sizes, brand preferences, and grocery spending patterns are all shifting.
Fashion & Apparel Wardrobe replacement cycles are accelerating. Consumers are spending more on clothing as body sizes change, with particular growth in transitional and versatile sizing.
Health & Wellness Interestingly, GLP-1 users report increased — not decreased — spending on fitness and wellness. The medications are catalyzing broader health behavior changes.
Social & Dining Restaurant behavior is changing: smaller portions, more emphasis on experience over quantity, and shifting alcohol consumption patterns.
Industry Implications
Every consumer-facing industry needs to understand these shifts. The brands that adapt to changing consumption patterns will win; those that ignore the trend risk losing relevance.
Methodology
300 AI-moderated interviews across GLP-1 users and non-users, segmented by demographics, geography, and medication timeline.